Application 062124
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | NYSTATIN | NYSTATIN | OINTMENT;TOPICAL | 100,000 UNITS/GM | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062124-002 | NYSTATIN | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062124-002 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062124-002 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | RS | 1982-09-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062124-002 | AT | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | A-S Medication Solutions | 98bd8ccb-0c68-47b9-bcb4-c5d8217868d9 | 2026-07-24 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | PAI Holdings, LLC dba PAI Pharma | 28b4e26e-206a-4e8a-abfe-774b780e91c3 | 2026-07-21 | Adverse reactions | Nystatin NYSTATIN |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 0bb31239-fb77-442a-a9ee-ba61b45e7e68 | 2026-07-14 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 2d2c4f79-95b5-417e-b5c1-8fac1dd09ddc | 2026-07-09 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Kesin Pharma Corporation | 50737729-a4a4-e747-e063-6394a90adcc5 | 2026-06-30 | Adverse reactions | NYSTATIN NYSTATIN |
| NYSTATIN | NYSTATIN | Bryant Ranch Prepack | 4f6f59fb-ae7d-48e5-b23e-a1d92160974f | 2026-05-11 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Torrent Pharmaceuticals Limited | 4949dea7-d2b9-4e0d-974a-39408fa174ba | 2026-05-08 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Genus Lifesciences Inc. | b25cbae5-eaf5-4501-b013-02c778ca4a4e | 2026-05-07 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Torrent Pharmaceuticals Limited | 559b5bd4-3564-4437-8d0a-fa3a972f8b83 | 2026-05-01 | Adverse reactions | Nystatin NYSTATIN |
| Mycostatin | NYSTATIN | Direct_Rx | f1857ac0-806c-4a7e-e053-2995a90abbc0 | 2026-03-17 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | f1b13a36-c349-4e26-a322-3ec02c610155 | 2026-03-16 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Chartwell RX, LLC | 9954118e-abe6-4388-98c9-4473d39b2e28 | 2026-03-05 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Cardinal Health 107, LLC | d59098da-1395-49fb-9fd6-947bbbeed56f | 2026-02-26 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Major Pharmaceuticals | 17b9e33d-da9c-467a-bbc4-9e257727f19a | 2026-02-23 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin Oral Suspension | NYSTATIN | Xttrium Laboratories, Inc. | 4a670371-d373-1ba6-e063-6394a90a13b6 | 2026-02-06 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | RedPharm Drug, Inc | f4c298d5-b012-7b56-e053-2a95a90a3d55 | 2026-01-24 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | ATLANTIC BIOLOGICALS CORP. | 5c08148f-83e5-4f14-b0d3-af8d2c26062e | 2026-01-13 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Chartwell RX, LLC | 30175930-f5fa-403d-a3ac-3bdbbe723641 | 2025-12-17 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Kesin Pharma Corporation | 43817169-bbe8-58ee-e063-6294a90a1250 | 2025-12-11 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Chartwell Governmental & Specialty RX, LLC | 88a0a22e-8d6b-42aa-b225-2d57fb5b3a97 | 2025-11-12 | Adverse reactions | Nystatin NYSTATIN |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0007 | Nystatin | nystatin | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |
| 42254-284 | Nystatin | nystatin | Rebel Distributors Corp | ANDA | Current |
| 50436-1425 | Nystatin | nystatin | Unit Dose Services | ANDA | Current |